Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor-Reference-Cited by-同舟云学术

Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor

Published:2013-05-07 Issue:8 Volume:41 Page:1470-1479
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Eng Heather,Sharma Raman,McDonald Thomas S.,Edmonds David J.,Fortin Jean-Philippe,Li Xianping,Stevens Benjamin D.,Griffith David A.,Limberakis Chris,Nolte Whitney M.,Price David A.,Jackson Margaret,Kalgutkar Amit S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference50 articles.

1. Immune mechanisms for induction of penicillin allergy;Ahlstedt;Prog Allergy,1982

2. Mass spectrometry in the analysis of glutathione conjugates

3. Penicillin Allergy: The Formation of the Penicilloyl Determinant

4. Binding properties of human albumin modified by covalent binding of penicillin

5. Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding sites and design strategies for small molecule GLP-1R agonists;European Journal of Medicinal Chemistry;2024-09

2. Prolonged Activation of the GLP-1 Receptor via Covalent Capture;ACS Chemical Biology;2024-06-27

3. Nickel-Catalyzed Antibody Bioconjugation;Journal of the American Chemical Society;2023-11-11

4. Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus;Obesity Medicine;2021-05

5. Non‐peptide agonists and positive allosteric modulators of glucagon‐like peptide‐1 receptors: Alternative approaches for treatment of Type 2 diabetes;British Journal of Pharmacology;2021-04-19